:::

詳目顯示

回上一頁
題名:Prescription Patterns and Safety Monitoring Practices in Medication for Youths with Attention-deficit/Hyperactivity Disorder
書刊名:Taiwanese Journal of Psychiatry
作者:吳洽明鄭淑文陳質采許元彰宋成賢劉士愷李國平
作者(外文):Wu, Chia-mingCheng, Shu-wenChen, Chih-tsaiHsu, Yuan-changSung, Cheng-hsienLiu, Shih-kaiLi, Kuo-ping
出版日期:2018
卷期:32:4
頁次:頁294-305+a2
主題關鍵詞:注意力不足過動症兒童青少年處方型態用藥安全Attention-deficit/hyperactivity disorderADHDYouthsPrescription patternMedication safety
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:10
期刊論文
1.Polanczyk, Guilherme、De Lima, Mauricio Silva、Horta, Bernardo Lessa、Biederman, Joseph R.、Rohde, Luis Augusta(2007)。The worldwide prevalence of ADHD: A systematic review and metaregression analysis。American Journal of Psychiatry,164(6),942-948。  new window
2.Pliszka, S. R.、Crismon, M. L.、Hughes, C. W.(2006)。Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Defi cit Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder。J Am Acad Child Adolesc Psychiatry,45,642-657。  new window
3.Pliszka, S.(2007)。Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder。J Am Acad Child Adolesc Psychiatry,46,894-921。  new window
4.Cortese, S.、Holtmann, M.、Banaschewksi, T.、Buitelaar, J.、Coghill, D.、Danckaerts, M.、Sergeant, J.(2013)。Practitioner review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents。Journal of Child Psychology and Psychiatry,54,227-246。  new window
5.Solomon, C. G.、Feldman, H. M.、Reiff, M. I.(2014)。Attention deficit-hyperactivity disorder in children and adolescents。N Engl J Med,370,838-846。  new window
6.Beau-Lejdstrom, R.、Douglas, I.、Evans, S. J.、Smeeth, L.(2016)。Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence。BMJ Open,6,e010508。  new window
7.Van Brunt, D. L.、Johnston, J. A.、Ye, W.(2005)。Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder。Pharmacotherapy,25,1541-1549。  new window
8.Hammemess, P. G.、Perrin, J. M.、Shelley-Abrahamson, R.、Wilens, T. E.(2011)。Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations。J Am Acad Child Adolesc Psychiatry,50,978-990。  new window
9.Briars, L.、Todd, T.(2016)。A review of pharmacological management of attention-deficit/hyperactivity disorder。J Pediatr Pharmacol Ther,21,192-206。  new window
10.Boland, F.、Galvin, R.、Reulbach, U.(2015)。Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study。BMC Pediatric,15,118。  new window
11.McCarthy, S.、Wilton, L.、Murray, M. L.、Hodgkins, P.、Asherson, P.、Wong, I. C. K.(2012)。The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care。BMC Pediatr,12,78。  new window
12.Wang, L. J.、Yang, K. C.、Lee, S. Y.(2016)。Initiation and persistence of pharmacotherapy for youths with attention deficit hyperactivity disorder in Taiwan。PLoS One,11(8)。  new window
13.Song, I.、Shin, J. Y.(2016)。Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011。Epidemiol Health,38,e2016045。  new window
14.Garbe, E.、Mikolajczyk, R. T.、Banaschewski, T.(2012)。Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study。J Child Adolesc Psychopharmacol,22,452-458。  new window
15.Shyu, Y. C.、Lee, S. Y.、Yuan, S. S.(2016)。Seasonal patterns of medications for treating attention-deficit/hyperactivity disorder: comparison of methylphenidate and atomoxetine。Clin Ther,38,595-602。  new window
16.Ghuman, J. K.、Arnold, L. E.、Anthony, B. J.(2008)。Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice。J Child Adolesc Psychopharmacol,18,413-447。  new window
17.Sonnack, M.、Brenneman, A.(2014)。Treatment strategies for ADHD in preschool and school-age children。J Am Acad Physician Assist,27,22-26。  new window
18.Greenhill, L.、Kollins, S.、Abikoff, H.(2006)。Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD。J Am Acad Child Adolesc Psychiatry,45,1284-1293。  new window
19.Schelleman, H.、Bilker, W. B.、Strom, B. L.(2011)。Cardiovascular events and death in children exposed and unexposed to ADHD agents。Pediatrics,127,1102-1110。  new window
20.Cooper, W. O.、Habel, L. A.、Sox, C. M.(2011)。ADHD drugs and serious cardiovascular events in children and young adults。N Engl J Med,365,1896-1904。  new window
21.Vitiello, B.、Elliott, G. R.、Swanson, J. M.(2012)。Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD。Am J Psychiatry,169,167-177。  new window
22.Murray, D. W.、Arnold, L. E.、Swanson, J.(2008)。A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA)。Curr Psychiatry Rep,10,424-431。  new window
23.Spencer, T. J.、Newcorn, J. H.、Kratochvil, C. J.、Ruff, D.、Michelson, D.、Biederman, J.(2005)。Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder。Pediatrics,116,e74-e80。  new window
24.Germinario, E. A.、Arcieri, R.、Bonati, M.(2013)。Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study。J Child Adolesc Psychopharmacol,23,440-447。  new window
25.Stein, M. A.、Sarampote, C. S.、Waldman, I. D.(2003)。A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder。Pediatrics,112,e404。  new window
26.Greenhill, L. L.、Swanson, James M.、Vitiello, B.(2001)。Impairment and Deportment Responses to Different Methylphenidate Doses in children with ADHD: The MTA Titration Trial。Journal of the American Academy of Child & Adolescent Psychiatry,40,180-187。  new window
27.Michelson, D.、Faries, D.、Wernicke, J.、Kelsey, D.、Kendrick, K.、Sallee, R.、Spencer, T.(2001)。Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study。Pediatrics,108(5),e83-e91。  new window
28.Jensen P. S.、Hinshaw, S. P.、Swanson, J. M.、Greenhill, L. L.、Conners, C. K.、Arnold, L. E.、Wigal, T.(2001)。Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers。Journal of Developmental and Behavioral Pediatrics,22,60-73。  new window
圖書論文
1.American Psychiatric Association、Baird, G.、Cook, E. H.、Happé, F. G.(2013)。Attention-deficit/hyperactivity disorder。Diagnostic and statistical manual of mental disorders。Washington, DC:American Psychiatric Association。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關期刊論文
 
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE